TNF and infection: On anti-TNFα treatment > 5% of patients reported infection (8 patients; 14.0%), nausea (4 patients; 7.0%), anemia (4 patients; 7.0%), arthralgia (3 patients; 5.3%) and eczema (3 patients; 5.3%).